Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Leweke

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Pharmacopsychiatry|March 2, 2010
Familial differential treatment response in schizophrenia--lessons from a case of three affected siblingsC Hoyer, L Kranaster, F M Leweke, et al.
Der Nervenarzt|July 1, 1997
[Pro-psychotic change of binocular depth inversion by sleep deprivation]U Sternemann, U Schneider, F M Leweke, et al.
Journal of Proteome Research|September 10, 2008
High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramidesEmanuel Schwarz, Sudhakaran Prabakaran, Phil Whitfield, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2007
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depressionD Koethe, I C Llenos, J R Dulay, et al.
Schizophrenia Research|December 1, 2001
Reduced binocular depth inversion in schizophrenic patientsU Schneider, M Borsutzky, J Seifert, et al.
Translational Psychiatry|July 27, 2012
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaF M Leweke, D Piomelli, F Pahlisch, et al.
Molecular Psychiatry|November 13, 2008
Differential effects on T-cell function following exposure to serum from schizophrenia smokersM Herberth, D N Krzyszton, D Koethe, et al.
Comprehensive Psychiatry|May 29, 2016
Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorderJ M Bumb, F Enning, J K Mueller, et al.
Translational Psychiatry|July 15, 2015
Serum proteomic profiling of major depressive disorderM Bot, M K Chan, R Jansen, et al.
Molecular Psychiatry|June 30, 2010
Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patientsM Herberth, D Koethe, T M K Cheng, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Pharmacopsychiatry|March 2, 2010
Familial differential treatment response in schizophrenia--lessons from a case of three affected siblingsC Hoyer, L Kranaster, F M Leweke, et al.
Der Nervenarzt|July 1, 1997
[Pro-psychotic change of binocular depth inversion by sleep deprivation]U Sternemann, U Schneider, F M Leweke, et al.
Journal of Proteome Research|September 10, 2008
High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramidesEmanuel Schwarz, Sudhakaran Prabakaran, Phil Whitfield, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 21, 2007
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depressionD Koethe, I C Llenos, J R Dulay, et al.
Schizophrenia Research|December 1, 2001
Reduced binocular depth inversion in schizophrenic patientsU Schneider, M Borsutzky, J Seifert, et al.
Translational Psychiatry|July 27, 2012
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaF M Leweke, D Piomelli, F Pahlisch, et al.
Molecular Psychiatry|November 13, 2008
Differential effects on T-cell function following exposure to serum from schizophrenia smokersM Herberth, D N Krzyszton, D Koethe, et al.
Comprehensive Psychiatry|May 29, 2016
Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorderJ M Bumb, F Enning, J K Mueller, et al.
Translational Psychiatry|July 15, 2015
Serum proteomic profiling of major depressive disorderM Bot, M K Chan, R Jansen, et al.
Molecular Psychiatry|June 30, 2010
Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patientsM Herberth, D Koethe, T M K Cheng, et al.
Pageof 4